Key result
Lower myocardial contraction fraction is linked to ~50% higher major cardiovascular events risk before LVEF adjustment.
Why the study?
Impaired myocardial function can coexist with a normal LVEF, and myocardial contraction fraction (MCF) may identify risk of major adverse cardiovascular events not captured by LVEF.
Is lower echocardiographic myocardial contraction fraction (MCF) associated with major adverse cardiovascular events (MACE) overall and by LVEF category?
Case-Control (n=249)
No
Is lower echocardiographic myocardial contraction fraction (MCF) associated with major adverse cardiovascular events (MACE) overall and by LVEF category?
Answers are grounded in this paper and cite their sources.
Echocardiographic myocardial contraction fraction (MCF) is associated with major adverse cardiovascular events, particularly in patients with preserved LVEF (≥50%), suggesting potential utility as a complementary risk marker to LVEF.
Background/Objectives: Impaired myocardial function can coexist with a normal left ventricular ejection fraction (LVEF). Myocardial contraction fraction (MCF), defined as stroke volume indexed to myocardial volume, may identify risk not captured by LVEF. This study examined the association between MCF and major adverse cardiovascular events (MACEs), overall and by LVEF category. Methods: In this case–control study at a tertiary centre in Saudi Arabia, 83 patients with MACE (coronary heart disease, stroke, arrhythmia, urgent valve surgery or transplantation, heart failure hospitalisation, or cardiovascular death) were individually matched 1:2 by age and sex to 166 event-free controls. MCF was calculated from routine echocardiographic measurements. Logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) per 1-SD decrease in MCF, adjusting for clinical risk factors and LVEF, with prespecified subgroup analysis by LVEF ≥ 50% vs. <50%. Results: Mean age was 57.9 ± 12.8 years; 59% were male. Median follow-up was 4.5 years (IQR: 3.3–5.1). The proportion of patients with MACE increased from 23.2% in the highest MCF tertile to 43.9% in the lowest (p for trend = 0.005). Lower MCF was associated with MACE after adjustment for clinical risk factors (OR: 1.50, 95% CI: 1.10–2.05), but not after further adjustment for LVEF (OR: 1.33, 95% CI: 0.92–1.91) or prior coronary artery disease and heart failure (OR: 1.37, 95% CI: 0.99–1.88). In patients with preserved LVEF, lower MCF was associated with MACE (OR: 1.62, 95% CI: 1.07–2.46), but not in those with reduced LVEF (OR: 0.77, 95% CI: 0.36–1.67; p for interaction = 0.088). Conclusions: Lower MCF was associated with MACE after adjustment for clinical risk factors, although this association was attenuated following additional adjustment for prior cardiovascular disease and LVEF; subgroup findings are hypothesis-generating. MCF warrants further evaluation as a complement to LVEF in larger prospective studies, particularly when LVEF is preserved.
No takes yet. Share an insight, caveat, or question.
Lamia Al Saikhan (2026) conducted a case-control in Major adverse cardiovascular events (MACE) (n=249). Myocardial contraction fraction (MCF) per 1-SD decrease vs. Event-free matched controls / higher MCF tertiles was evaluated on Major adverse cardiovascular events (coronary heart disease, stroke, arrhythmia, urgent valve surgery or transplantation, heart failure hospitalisation, or cardiovascular death) (OR 1.50, 95% CI 1.10-2.05, p=0.005 for trend across tertiles). Lower myocardial contraction fraction was associated with major cardiovascular events after clinical risk adjustment, but attenuated after LVEF adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: